Genmab | L'Utile Operativo

Prezzo Delle Azioni
1,931.50
Cambio Giornaliero
-26.50 -1.35%
Mensile
-10.66%
Annuale
41.24%
Q1 Previsione
1,860.10




L'Utile Operativo Cambiamento Data
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
Almirall EUR 43.02M 28.78M 2025-06
Amarin USD -1.7M 8.47M 2025-09
Amgen USD 3.96B 464M 2025-12
argenx SE USD 349.97M 146.13M 2025-09
AstraZeneca USD -1.5B 5.01B 2025-09
Bayer EUR -543M 556M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Demant DKK 2.09B 224M 2025-12
Exelixis USD 256.36M 42.78M 2025-09
Fresenius Medical Care EUR 449.94M 18.94M 2025-09
Galapagos EUR -41.67M 15.36M 2025-09
Genmab DKK 360M 172M 2025-06
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GN Store Nord DKK 570M 230M 2025-12
GRIFOLS EUR 352.11M 2.57M 2025-09
Hikma Pharmaceutical USD 187M 95M 2025-06
Insmed USD -261.35M 7.48M 2025-09
Lonza CHF 430M 104M 2024-12
Merck EUR 1.21B 180M 2025-09
Novartis USD 4.5B 363M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
UCB EUR 1B 678M 2024-12


Genmab L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.